/u/WalkingHorse's posts in /r/LungCancerSupport

Year:

Only show posts with narrations

Overcoming resistance in small-cell lung cancer

1 upvotes

Mark as read: Add to a list

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer | Molecular Cancer

1 upvotes

Mark as read: Add to a list

Frontiers | The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance

1 upvotes

Mark as read: Add to a list

Construction of a nomogram model based on biomarkers for liver metastasis in non-small cell lung cancer

1 upvotes

Mark as read: Add to a list

Impact of body surface area on efficacy and safety in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib as a first-line treatment

1 upvotes

Mark as read: Add to a list

Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers | BMC Cancer

1 upvotes

Mark as read: Add to a list

Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations | BMC Cancer

1 upvotes

Mark as read: Add to a list

Postoperative chronic operation-related symptoms after minimally invasive lung surgery: a prospective observational protocol

1 upvotes

Mark as read: Add to a list

Airway Injury Related to Radiation Treatment and Durvalumab Treatment A Case Series

1 upvotes

Mark as read: Add to a list

Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients

1 upvotes

Mark as read: Add to a list

Title	Upvotes	Mark as read	Favorited	Rating	Add to a list
Overcoming resistance in small-cell lung cancer	1
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer \| Molecular Cancer	1
Frontiers \| The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance	1
Construction of a nomogram model based on biomarkers for liver metastasis in non-small cell lung cancer	1
Impact of body surface area on efficacy and safety in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib as a first-line treatment	1
Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers \| BMC Cancer	1
Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations \| BMC Cancer	1
Postoperative chronic operation-related symptoms after minimally invasive lung surgery: a prospective observational protocol	1
Airway Injury Related to Radiation Treatment and Durvalumab Treatment A Case Series	1
Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients	1